|
| Avi J Samelson | Institute for Neurodegenerative Diseases, University of California san francisco |
| Avi J Samelson | |
| R??my Robinot | Institut Pasteur, CNRS UMR 3569 |
| Veronica V Rezelj | Institut Pasteur, CNRS UMR 3569 |
| Irene Lui | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Jared Carlson-Stevermer | Synthego Corporation, Massachusetts Institute of Technology |
| Jennifer Oki | Synthego Corporation, Massachusetts Institute of Technology |
| Travis J Maures | Synthego Corporation, Massachusetts Institute of Technology |
| Kevin Holden | Synthego Corporation, Massachusetts Institute of Technology |
| Jonathan S Weissman | University of California san francisco |
| Jonathan S Weissman | Howard Hughes Medical Institute, University of California san francisco |
| Jonathan S Weissman | Whitehead Institute for Biomedical Research, Innovative Genomics Institute |
| James A Wells | |
| James A Wells | Department of Pharmaceutical Chemistry, University of California San Francisco |
| James A Wells | University of California san francisco |
| Bruce R Conklin | Gladstone Institutes |
| Bruce R Conklin | University of California san francisco |
| Bruce R Conklin | University of California san francisco |
| Bruce R Conklin | University of California san francisco |
| Benjamin R tenOever | Icahn School of Medicine |
| Marco Vignuzzi | Institut Pasteur, CNRS UMR 3569 |
| Martin Kampmann | Institute for Neurodegenerative Diseases, University of California san francisco |
| Martin Kampmann | |
| Martin Kampmann | University of California san francisco |